This partnership
is personal

Genomic solutions to change how cancer will be identified and treated

Future of NGS in Oncology

As genomics-focused pharmacology begins to play a greater role in cancer treatment, next-generation sequencing (NGS) is emerging as a valuable method for obtaining a deeper and more accurate look into the molecular underpinnings of individual tumors. With targeted therapies becoming the new standard of care in oncology, NGS-driven companion diagnostics are widely seen as driving the selection of treatments to optimize patient outcomes in the future.

Initiatives such as the Understand Your Genome (UYG) symposium aim to educate patients and providers on the future promise of personalized medicine. This event brings the professional and practitioner community together to discuss the clinical potential of NGS, with the hope that these conversations will inform how society pursues the journey to individualized health care.

NGS has the potential to change the future of oncology and advance the promise of personalized medicine. We invite you to learn more by examining the resources collected here.

Introduction to NGS for Oncologists

Learn more about NGS technology and the role it might play in clinical oncology in the future.

Access PDF
Genomic Applications in Oncology

The Medical Affairs team at Illumina discusses the applications of genomics in oncology for risk prediction and precision medicine.

Learn More
Interested in receiving newsletters, case studies, and information on cancer genomics?
Sign Up
Understand Your Genome

The symposium aims to engage, educate, and motivate the clinical community towards the future of personalized medicine.

Learn More
Medical Genetics Education

Find educational resources about medical genetics and learn how genomic information can be used in clinical practice.

Learn More
Genomics Powers Access to Cancer Breakthroughs
Genomics Powers Access to Cancer Breakthroughs

Garret Hampton, EVP of Clinical Genomics at Illumina, shares his vision for how genomics might shape the future of oncology.

Read Interview